| Date | Form | Description | Docs | XBRL | Pages |
| 06/23/97 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/13/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/09/97 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
10 | |
| 03/14/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
26 | |
| 01/31/97 | 10-K405/A |
|
2 | ||
| 01/29/97 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
35 | |
| 11/27/96 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
11 | |
| 09/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 06/24/96 | DEF 14A | Definitive proxy statements |
|
14 | |
| 06/19/96 | 10-C |
|
2 |
Latest News & Events
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences Clarifies Poster Presentation on Company Website
Read More...Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Read More...